Behavioral Intervention using Messaging on Cigarette Smoking Related Cancer Risks

Inclusion Criteria

• Age >= 21 years (legal age to purchase tobacco in Minneapolis)
• Smoke at least 5 cigarettes/day for the past month (confirmed by carbon monoxide [CO] >= 8ppm or urine nicotine test confirming they are smoker);
• No intentions to quit smoking in the next 30 days
• Access to stable internet/data at home for online screening and surveys

Exclusion Criteria

• Unstable health conditions (any significant serious, unstable medical condition including, but not limited to, cardiovascular disease, unstable chronic obstructive pulmonary disease [COPD], seizure disorder (seizure within the last year), blood pressure, heart rate and cancer) as determined by medical history and after review by the licensed medical professional
• Unstable mental health (to be determined by medical history and after review by the licensed medical professional)
• Planning to become pregnant, pregnant (confirmed through a urine test), or breastfeeding
• Participation in a LNC cigarette study or Spectrum cigarette study in the past 1 year
• Currently taking any one of the following medications indicative of serious heart condition or seizures or current cancer treatment: * Phenytoin [Brand Name: Dilantin] (if unstable) * Carbamazepine [Brand Name: Tegretol, Carbatrol, Equetro, Epitol] (if unstable) * Oxcarbazepine [Brand Name: Trileptal] (if unstable) * Primidone [Brand Name: Mysoline] (if unstable) * Phenobarbital (if unstable) * Bendamustine [Brand Name: Treanda] * Erlotinib [Brand Name: Tarceva] * Flecainide [Brand Name: Tambocor] * Irinotecan [Brand Name: Camptosar]
• Inability to independently read and comprehend the consent form and other written study materials and measures because participants are required to complete parts of the protocol at home independently